152 related articles for article (PubMed ID: 9268501)
1. FLT3 ligand induces the generation of functionally active dendritic cells in mice.
Shurin MR; Pandharipande PP; Zorina TD; Haluszczak C; Subbotin VM; Hunter O; Brumfield A; Storkus WJ; Maraskovsky E; Lotze MT
Cell Immunol; 1997 Aug; 179(2):174-84. PubMed ID: 9268501
[TBL] [Abstract][Full Text] [Related]
2. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.
Ohm JE; Shurin MR; Esche C; Lotze MT; Carbone DP; Gabrilovich DI
J Immunol; 1999 Sep; 163(6):3260-8. PubMed ID: 10477595
[TBL] [Abstract][Full Text] [Related]
3. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver.
Drakes ML; Lu L; Subbotin VM; Thomson AW
J Immunol; 1997 Nov; 159(9):4268-78. PubMed ID: 9379022
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivo.
Esche C; Cai Q; Peron JM; Hunter O; Subbotin VM; Lotze MT; Shurin MR
Eur J Immunol; 2000 Sep; 30(9):2565-75. PubMed ID: 11009090
[TBL] [Abstract][Full Text] [Related]
6. FLT3-ligand administration inhibits liver metastases: role of NK cells.
Péron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
[TBL] [Abstract][Full Text] [Related]
7. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
[TBL] [Abstract][Full Text] [Related]
8. CD8+, CD8-, and plasmacytoid dendritic cell generation in vitro using flt3 ligand.
Naik SH; O'Keeffe M; Proietto A; Shortman HH; Wu L
Methods Mol Biol; 2010; 595():167-76. PubMed ID: 19941111
[TBL] [Abstract][Full Text] [Related]
9. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness.
Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M
Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735
[TBL] [Abstract][Full Text] [Related]
11. Cytokines in the generation and maturation of dendritic cells: recent advances.
Zou GM; Tam YK
Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074
[TBL] [Abstract][Full Text] [Related]
12. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice.
Pulendran B; Lingappa J; Kennedy MK; Smith J; Teepe M; Rudensky A; Maliszewski CR; Maraskovsky E
J Immunol; 1997 Sep; 159(5):2222-31. PubMed ID: 9278310
[TBL] [Abstract][Full Text] [Related]
13. Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-alpha production.
Vollstedt S; O'Keeffe M; Odermatt B; Beat R; Glanzmann B; Riesen M; Shortman K; Suter M
Eur J Immunol; 2004 Jul; 34(7):1849-60. PubMed ID: 15214033
[TBL] [Abstract][Full Text] [Related]
14. Generation of mature dendritic cells from a CD14+ cell line (XS52) by IL-4, TNF-alpha, IL-1 beta, and agonistic anti-CD40 monoclonal antibody.
Yamada N; Katz SI
J Immunol; 1999 Nov; 163(10):5331-7. PubMed ID: 10553056
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human Flt3 ligand exerts both direct and indirect effects on hematopoiesis.
Xu Z; Xu Y; Zhu J; Shi Q; Li Y; Zhang X
Chin Med J (Engl); 2002 Feb; 115(2):202-5. PubMed ID: 11940331
[TBL] [Abstract][Full Text] [Related]
16. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells.
Gorczynski L; Chen Z; Hu J; Kai Y; Lei J; Ramakrishna V; Gorczynski RM
J Immunol; 1999 Jan; 162(2):774-81. PubMed ID: 9916698
[TBL] [Abstract][Full Text] [Related]
17. Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand.
Shurin GV; Chatta GS; Tourkova IL; Zorina TD; Esche C; Shurin MR
Exp Gerontol; 2004 Mar; 39(3):339-48. PubMed ID: 15036393
[TBL] [Abstract][Full Text] [Related]
18. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.
Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
Cancer Res; 1998 Feb; 58(3):380-3. PubMed ID: 9458075
[TBL] [Abstract][Full Text] [Related]
19. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo.
Lau AH; Abe M; Thomson AW
J Leukoc Biol; 2006 May; 79(5):941-53. PubMed ID: 16478920
[TBL] [Abstract][Full Text] [Related]
20. The generation of plasmacytoid and conventional dendritic cells with M-CSF.
O'Keeffe M; Fancke B; Hochrein H
Methods Mol Biol; 2010; 595():187-93. PubMed ID: 19941113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
